Journal of the American Society of Hypertension
Volume 4, Issue 4 , Pages 187-195 , July 2010

Enhanced blood pressure variability in a high cardiovascular risk group of African Americans: FIT4Life Study

  • Praveen Veerabhadrappa, MD, MS

      Affiliations

    • Hypertension, Molecular and Applied Physiology Laboratory, Department of Kinesiology, College of Health Professions, Temple University, Philadelphia, PA
    • Corresponding Author InformationCorresponding author: Praveen Veerabhadrappa, MD, MS, Hypertension, Molecular and Applied Physiology Laboratory, Department of Kinesiology, College of Health Professions, Temple University, 1800 N. Broad Street, Philadelphia, PA 19122. Tel: 215-204-0084; fax: 215-204-4414.
    • ,
  • Keith M. Diaz, BS

      Affiliations

    • Hypertension, Molecular and Applied Physiology Laboratory, Department of Kinesiology, College of Health Professions, Temple University, Philadelphia, PA
    • ,
  • Deborah L. Feairheller, BS

      Affiliations

    • Hypertension, Molecular and Applied Physiology Laboratory, Department of Kinesiology, College of Health Professions, Temple University, Philadelphia, PA
    • ,
  • Kathleen M. Sturgeon, MEd

      Affiliations

    • Hypertension, Molecular and Applied Physiology Laboratory, Department of Kinesiology, College of Health Professions, Temple University, Philadelphia, PA
    • ,
  • Sheara Williamson, MS

      Affiliations

    • Hypertension, Molecular and Applied Physiology Laboratory, Department of Kinesiology, College of Health Professions, Temple University, Philadelphia, PA
    • ,
  • Deborah L. Crabbe, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Temple University, Philadelphia, PA
    • Cardiovascular Research Center, School of Medicine, Temple University, Philadelphia, PA
    • ,
  • Abul Kashem, MD, PhD

      Affiliations

    • Division of Cardiology, Department of Medicine, Temple University, Philadelphia, PA
    • Cardiovascular Research Center, School of Medicine, Temple University, Philadelphia, PA
    • ,
  • Debra Ahrensfield, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Temple University, Philadelphia, PA
    • ,
  • Michael D. Brown, PhD

      Affiliations

    • Hypertension, Molecular and Applied Physiology Laboratory, Department of Kinesiology, College of Health Professions, Temple University, Philadelphia, PA
    • Cardiovascular Research Center, School of Medicine, Temple University, Philadelphia, PA

Received 9 April 2010 ,Accepted 22 April 2010.

References 

  1. Francis CK. Hypertension, cardiac disease, and compliance in minority patients. Am J Med. 1991;91:29S–36S
  2. Sowers JR, Ferdinand KC, Bakris GL, Douglas JG. Hypertension-related disease in African Americans. Factors underlying disparities in illness and its outcome. Postgrad Med. 2002;112:24–3033
  3. Ferdinand KC. Introduction: management of hypertension and cardiovascular risk factors in African Americans. J Clin Hypertens (Greenwich). 2003;5(1 Suppl 1):3–4
  4. Fiscella K, Holt K. Racial disparity in hypertension control: tallying the death toll. Ann Fam Med. 2008;6:497–502
  5. Libby P. Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization. Am J Cardiol. 2000 Oct 19;86:3J–8J
  6. Libby P, Ridker PM. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med. 2004;116(Suppl 6A):9S–16S
  7. Hernandez-Presa M, Bustos C, Ortego M, Tunon J, Renedo G, Ruiz-Ortega M, et al. Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation. 1997;95:1532–1541
  8. Schillaci G, Pirro M, Gemelli F, Pasqualini L, Vaudo G, Marchesi S, et al. Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressures. J Hypertens. 2003;21:1841–1846
  9. Chrysohoou C, Pitsavos C, Panagiotakos DB, Skoumas J, Stefanadis C. Association between prehypertension status and inflammatory markers related to atherosclerotic disease: the ATTICA Study. Am J Hypertens. 2004;17:568–573
  10. Lakoski SG, Cushman M, Palmas W, Blumenthal R, D'Agostino RB, Herrington DM. The relationship between blood pressure and C-reactive protein in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol. 2005;46:1869–1874
  11. Kalinowski L, Dobrucki IT, Malinski T. Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases. Circulation. 2004;109:2511–2517
  12. Klag MJ. Hypertension in African Americans. Ann Epidemiol. 1996;6:171–172
  13. Bowman SA. Socioeconomic characteristics, dietary and lifestyle patterns, and health and weight status of older adults in NHANES, 1999–2002: a comparison of Caucasians and African Americans. J Nutr Elder. 2009;28:30–46
  14. Choi JB, Hong S, Nelesen R, Bardwell WA, Natarajan L, Schubert C, et al. Age and ethnicity differences in short-term heart-rate variability. Psychosom Med. 2006;68:421–426
  15. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol. 2006;6:508–519
  16. Musini VM, Wright JM. Factors affecting blood pressure variability: lessons learned from two systematic reviews of randomized controlled trials. PLoS One. 2009;4:e5673
  17. Parati G, Lantelme P. Blood pressure variability, target organ damage and cardiovascular events. J Hypertens. 2002;20:1725–1729
  18. Tatasciore A, Zimarino M, Renda G, Zurro M, Soccio M, Prontera C, et al. Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension. Hypertension Res. 2008;31:2137–2146
  19. Tatasciore A, Renda G, Zimarino M, Soccio M, Bilo G, Parati G, et al. Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects. Hypertension. 2007;50:325–332
  20. Mena L, Pintos S, Queipo NV, Aizpurua JA, Maestre G, Sulbaran T. A reliable index for the prognostic significance of blood pressure variability. J Hypertens. 2005;23:505–511
  21. Pearson TA, Mensah GA, Hong Y, Smith SC. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: overview. Circulation. 2004;110:e543–e544
  22. Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24-hour blood pressure variability. J Hypertens 199;11:1133–7.
  23. Pierdomenico SD, Di NM, Esposito AL, Di MR, Ballone E, Lapenna D, et al. Prognostic value of different indices of blood pressure variability in hypertensive patients. Am J Hypertens. 2009;22:842–847
  24. Parati G, Bilo G, Vettorello M, Groppelli A, Maronati A, Tortorici E, et al. Assessment of overall blood pressure variability and its different components. Blood Press Monit. 2003;8:155–159
  25. Hansen TW, Li Y, Staessen JA. Blood pressure variability remains an elusive predictor of cardiovascular outcome. Am J Hypertens. 2009;22:3–4
  26. Chobanian AV, Bakris GL, Black HR. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–1252
  27. Parati G. Blood pressure variability: its measurement and significance in hypertension. J Hypertens Suppl. 2005;23:S19
  28. Parati G, Rizzoni D. Assessing the prognostic relevance of blood pressure variability: discrepant information from different indices. J Hypertens. 2005;23:483–486
  29. Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, Trevano FQ, et al. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension. 2007;49:1265–1270
  30. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111:1805–1812
  31. Sesso HD, Buring JE, Rifai N. C-reactive protein and the risk of developing hypertension. JAMA. 2003;290:2945–2951
  32. Lakoski SG, Cushman M, Palmas W, Blumenthal R, D'Agostino RB, Herrington DM. The relationship between blood pressure and C-reactive protein in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol. 2005;46:1869–1874
  33. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension. 2001;38:581–587
  34. Engstrom G, Janzon L, Berglund G. Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins. Arterioscler Thromb Vasc Biol. 2002;22:2054–2058
  35. Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension. 2001;38:399–403
  36. Bautista LE, Atwood JE, O'Malley PG. Association between C-reactive protein and hypertension in healthy middle-aged men and women. Coron Artery Dis. 2004;15:331–336
  37. Abramson JL, Lewis C, Murrah NV. Relation of C-reactive protein and tumor necrosis factor-alpha to ambulatory blood pressure variability in healthy adults. Am J Cardiol. 2006;98:649–652
  38. Kim KI, Lee JH, Chang HJ, Cho YS, Youn TJ, Chung WY, et al. Association between blood pressure variability and inflammatory marker in hypertensive patients. Circ J. 2008;72:293–298
  39. Blaber AP, Bondar RL, Freeman R. Coarse graining spectral analysis of HR and BP variability in patients with autonomic failure. Am J Physiol. 1996;271(4 Pt 2):H1555–H1564

 Supported by NIH/NHLBI Grant RO1 HL085497 (PI, Michael Brown) and by NIH/NIA Grant KO1 AG019640 (PI, Michael Brown).

PII: S1933-1711(10)00115-4

doi: 10.1016/j.jash.2010.04.005

Journal of the American Society of Hypertension
Volume 4, Issue 4 , Pages 187-195 , July 2010

Article Tools

* Image Usage & Resolution